Holen Sie sich die Stockscreener-App
125.81
0.74%
0.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt A?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$124.88
Offen:
$125.6
24-Stunden-Volumen:
1.53M
Relative Volume:
0.76
Marktkapitalisierung:
$35.58B
Einnahmen:
$6.95B
Nettoeinkommen (Verlust:
$1.30B
KGV:
27.53
EPS:
4.5696
Netto-Cashflow:
$1.15B
1W Leistung:
-2.91%
1M Leistung:
-14.02%
6M Leistung:
+4.59%
1J Leistung:
-7.80%
1-Tages-Spanne:
$125.02
$127.77
1-Wochen-Bereich:
$120.99
$129.97
52-Wochen-Spanne:
$96.43
$160.27
Agilent Technologies Inc Stock (A) Company Profile
Firmenname
Agilent Technologies Inc
Sektor
Branche
Telefon
(408) 345-8886
Adresse
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Compare A vs TMO, DHR, IDXX, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Agilent Technologies Inc Stock (A) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-20 | Eingeleitet | HSBC Securities | Buy |
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-12-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2025-10-08 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-10-08 | Hochstufung | UBS | Neutral → Buy |
| 2025-02-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-04-05 | Hochstufung | Stifel | Hold → Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-11-17 | Herabstufung | UBS | Buy → Neutral |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-05-24 | Bestätigt | Barclays | Equal Weight |
| 2023-05-24 | Bestätigt | BofA Securities | Buy |
| 2023-05-24 | Bestätigt | Citigroup | Neutral |
| 2023-05-24 | Bestätigt | Credit Suisse | Outperform |
| 2023-05-24 | Bestätigt | Evercore ISI | Outperform |
| 2023-05-24 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-24 | Bestätigt | Robert W. Baird | Outperform |
| 2023-05-24 | Bestätigt | SVB Securities | Outperform |
| 2023-05-24 | Bestätigt | Stifel | Hold |
| 2023-05-24 | Bestätigt | TD Cowen | Outperform |
| 2023-05-24 | Bestätigt | Wells Fargo | Overweight |
| 2023-05-11 | Eingeleitet | Barclays | Equal Weight |
| 2023-01-10 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2022-07-08 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-02-23 | Bestätigt | BofA Securities | Buy |
| 2022-02-23 | Bestätigt | Citigroup | Buy |
| 2022-02-23 | Bestätigt | Cowen | Outperform |
| 2022-02-23 | Bestätigt | Evercore ISI | Outperform |
| 2022-02-23 | Bestätigt | Stifel | Hold |
| 2022-02-23 | Bestätigt | Wells Fargo | Overweight |
| 2021-11-23 | Bestätigt | BofA Securities | Buy |
| 2021-11-23 | Bestätigt | Cowen | Outperform |
| 2021-11-23 | Bestätigt | Stifel | Hold |
| 2021-03-18 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Hochstufung | BofA Securities | Neutral → Buy |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-25 | Hochstufung | UBS | Neutral → Buy |
| 2020-11-17 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Neutral |
| 2020-08-19 | Bestätigt | BofA Securities | Neutral |
| 2020-08-19 | Bestätigt | Citigroup | Neutral |
| 2020-08-19 | Bestätigt | Jefferies | Buy |
| 2020-08-19 | Bestätigt | Robert W. Baird | Outperform |
| 2020-08-19 | Bestätigt | SVB Leerink | Outperform |
| 2020-08-19 | Bestätigt | Stifel | Hold |
| 2020-08-19 | Bestätigt | Wells Fargo | Overweight |
| 2020-02-24 | Herabstufung | Needham | Buy → Hold |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Neutral |
| 2019-11-26 | Bestätigt | Needham | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-10-18 | Herabstufung | UBS | Buy → Neutral |
| 2019-07-16 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-07-15 | Herabstufung | Barclays | Overweight → Equal Weight |
Alle ansehen
Agilent Technologies Inc Aktie (A) Neueste Nachrichten
Agilent Technologies, Inc. $A Shares Sold by ING Groep NV - MarketBeat
Assetmark Inc. Boosts Position in Agilent Technologies, Inc. $A - MarketBeat
BofA Maintains Hold Rating on Agilent Technologies (A) After Q2 Report - MSN
How is Agilent Technologies' stock performance compared to other healthcare stocks? - MSN
Agilent Technologies, Inc.'s (NYSE:A) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - Yahoo Finance
Agilent Technologies, Inc. $A Shares Sold by Rhumbline Advisers - MarketBeat
Agilent Technologies, Inc. (NYSE:A) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Agilent Technologies (NYSE:A) Boosts The S&P 500 Fund With Scientific Excellence - Kalkine Media
Agilent Technologies Inc (A) Shares Gap Down to $122.07 on Feb 1 - GuruFocus
Agilent Technologies, Inc. (NYSE:A) to Issue $0.26 Quarterly Dividend - MarketBeat
Agilent (A) Secures FDA Approval for Key Cancer Diagnostic Tool - GuruFocus
Agilent Receives FDA Approval for PD-L1 IHC 22C3 pharmDx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma (EOC) - Yahoo Finance
Agilent Announces Cash Dividend of 25.5 Cents per Share - 01net
Agilent presents Boehringer Ingelheim with inaugural 2025 instrument Trade-in Impact Award - marketscreener.com
Is Agilent Technologies Inc. showing insider buyingRate Cut & Low Risk High Reward Trade Ideas - mfd.ru
Agilent Slumps After Awarding Boehringer - Baystreet.ca
Agilent's Ovarian Cancer Diagnostic Test Receives FDA Clearance - marketscreener.com
FDA Approval Boosts Agilent Technologies (A) Diagnostic Tool - GuruFocus
Agilent Presents Boehringer Ingelheim With Inaugural 2025 Instrument Trade‑In Impact Award - Bluefield Daily Telegraph
Madison Asset Management LLC Sells 14,089 Shares of Agilent Technologies, Inc. $A - MarketBeat
Gas Chromatography Detector Market Is Going to Boom |• Agilent Technologies • Thermo Fisher Scientific - openPR.com
Agilent Technologies, Inc. $A Position Cut by Impax Asset Management Group plc - MarketBeat
Agilent Technologies - Forbes
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence - Quantisnow
Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A) - Yahoo Finance
Candriam S.C.A. Increases Holdings in Agilent Technologies, Inc. $A - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in Agilent Technologies, Inc. $A - MarketBeat
Federated Hermes Inc. Has $273,000 Stock Position in Agilent Technologies, Inc. $A - MarketBeat
AGILENT TECHNOLOGIES, INC. ($A) CEO 2025 Pay Revealed - Quiver Quantitative
AAgilent Technologies Inc Stock Price and Quote - Finviz
What's Driving the Market Sentiment Around Agilent Technologies Inc? - Benzinga
Form DEFA14A AGILENT TECHNOLOGIES, - StreetInsider
Linscomb Wealth Inc. Invests $2.94 Million in Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies (A) Valuation Check After New Automation And AI Lab Tools Showcase - Sahm
Agilent Showcases Next‑Generation Automated Solutions at SLAS2026 - BioSpace
Does Agilent Technologies (NYSE:A) Have A Healthy Balance Sheet? - Yahoo Finance
Agilent Ekes up Ahead of Next Week’s Boston Fair - Baystreet.ca
Agilent Technologies Inc. Showcases Next-Generation Automated Solutions at SLAS2026 - marketscreener.com
Allianz Asset Management GmbH Has $96.71 Million Position in Agilent Technologies, Inc. $A - MarketBeat
Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25 - BioSpace
Agilent Technologies : and Virscidian Announce Collaboration to Streamline Access to OpenLab CDS Data in Analytical Studio - marketscreener.com
Mediolanum International Funds Ltd Sells 15,620 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent Technologies, Inc. (A) Stock Analysis: Potential 26.76% Upside Raises Investor Optimism - DirectorsTalk Interviews
Agilent Technologies price tries to recoup some lossesForecast today02-02-2026 - Economies.com
National Pension Service Acquires 11,841 Shares of Agilent Technologies, Inc. $A - MarketBeat
AE Wealth Management LLC Has $9.54 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat
Chromatograph (Labor): Why Agilent’s Lab Chromatography Systems Are Quietly Powering the Most Impo - AD HOC NEWS
Is Now The Time To Look At Buying Agilent Technologies, Inc. (NYSE:A)? - Yahoo Finance
Mutual of America Capital Management LLC Sells 12,121 Shares of Agilent Technologies, Inc. $A - MarketBeat
Chromatography Research Report 2026 - GlobeNewswire Inc.
Automated Sample Preparation Research Report 2026 - GlobeNewswire Inc.
Finanzdaten der Agilent Technologies Inc-Aktie (A)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):